SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-18-002984
Filing Date
2018-09-20
Accepted
2018-09-20 19:33:48
Documents
1
Period of Report
2018-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7608
  Complete submission text file 0001567619-18-002984.txt   9325
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139
Business Address
Feener Edward P. (Reporting) CIK: 0001691090 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 181080375